Primary |
Type 2 Diabetes Mellitus |
66.7% |
Hypertension |
33.3% |
|
White Blood Cell Count Decreased |
50.0% |
White Blood Cell Count Increased |
50.0% |
|
Secondary |
Hypertension |
32.5% |
Hiv Infection |
10.0% |
Ill-defined Disorder |
6.3% |
Accidental Exposure |
5.0% |
Glaucoma |
5.0% |
Bipolar Disorder |
3.8% |
Drug Use For Unknown Indication |
3.8% |
Osteoporosis |
3.8% |
Prophylaxis |
3.8% |
Anxiety |
2.5% |
Asthma |
2.5% |
Bronchopneumonia |
2.5% |
Coronary Arterial Stent Insertion |
2.5% |
Coronary Artery Stenosis |
2.5% |
Hiatus Hernia |
2.5% |
Hypercholesterolaemia |
2.5% |
Major Depression |
2.5% |
Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
Sicca Syndrome |
2.5% |
Abdominal Pain Upper |
1.3% |
|
Renal Failure Acute |
18.8% |
Interstitial Lung Disease |
12.5% |
Hyponatraemia |
9.4% |
Idiopathic Thrombocytopenic Purpura |
6.3% |
Paralysis |
6.3% |
Accidental Drug Intake By Child |
3.1% |
Asthenia |
3.1% |
Crystal Arthropathy |
3.1% |
Drug Interaction |
3.1% |
Gastrooesophageal Reflux Disease |
3.1% |
Hypokalaemia |
3.1% |
Inflammation |
3.1% |
Pain In Extremity |
3.1% |
Platelet Count Decreased |
3.1% |
Renal Failure |
3.1% |
Skin Ulcer |
3.1% |
Stillbirth |
3.1% |
Thrombocytosis |
3.1% |
Ulnar Nerve Palsy |
3.1% |
Vomiting |
3.1% |
|
Concomitant |
Hypertension |
21.3% |
Drug Use For Unknown Indication |
14.9% |
Rheumatoid Arthritis |
12.6% |
Product Used For Unknown Indication |
10.9% |
Type 2 Diabetes Mellitus |
8.3% |
Hepatitis C |
3.7% |
Diabetes Mellitus |
3.2% |
Pain |
2.9% |
Acne |
2.3% |
Hypercholesterolaemia |
2.3% |
Chemotherapy |
2.0% |
Osteoporosis |
2.0% |
Prophylaxis |
2.0% |
Cancer Pain |
1.7% |
Hiv Infection |
1.7% |
Osteoporosis Prophylaxis |
1.7% |
Prophylaxis Against Gastrointestinal Ulcer |
1.7% |
Unevaluable Event |
1.7% |
Asthma |
1.4% |
Premedication |
1.4% |
|
Thrombocytopenia |
10.7% |
Somnolence |
8.9% |
Henoch-schonlein Purpura |
7.1% |
Ventricular Fibrillation |
7.1% |
Oedematous Pancreatitis |
5.4% |
Pancreatitis |
5.4% |
Septic Shock |
5.4% |
Vomiting |
5.4% |
Weight Decreased |
5.4% |
Cardiac Failure |
3.6% |
Delirium |
3.6% |
Drug Ineffective |
3.6% |
Hallucination |
3.6% |
Hypertensive Nephropathy |
3.6% |
Lung Infection |
3.6% |
Osteolysis |
3.6% |
Pancreatitis Acute |
3.6% |
Rash Maculo-papular |
3.6% |
Renal Failure Chronic |
3.6% |
Rhabdomyolysis |
3.6% |
|
Interacting |
Hypertension |
45.8% |
Cough |
12.5% |
Hypertensive Cardiomyopathy |
12.5% |
Anxiety |
4.2% |
Arrhythmia |
4.2% |
Benign Prostatic Hyperplasia |
4.2% |
Drug Use For Unknown Indication |
4.2% |
Mental Impairment |
4.2% |
Product Used For Unknown Indication |
4.2% |
Prophylaxis |
4.2% |
|
Renal Failure Acute |
50.0% |
Drug Interaction |
16.7% |
Rectal Haemorrhage |
16.7% |
Spinal Compression Fracture |
16.7% |
|